NFKB1 and melanoma: It has been shown that A375 human melanoma cells, which present high constitutive levels of NF-κB, treated with different concentrations of synthetic NBD peptide, undergo a growth arrest in a dose-dependent manner; this effect is accompanied and strengthened by the impaired ability of NF-κB to bind to DNA [43].